Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Michels

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Cell Cycle (Georgetown, Tex.)|January 5, 2013
Vitamin B6 metabolism influences the intracellular accumulation of cisplatinLorenzo Galluzzi, Sabrina Marsili, Ilio Vitale, et al.
Bulletin Du Cancer|November 14, 2024
[Practical application of the 2023 FIGO classification for endometrial cancer]Solène Grosse, Catherine Genestie, Stéphanie Scherier, et al.
Plos One|June 6, 2012
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinomaOlivier Mir, Romain Coriat, Benoit Blanchet, et al.
Biochemical Pharmacology|August 10, 2014
MCL-1 dependency of cisplatin-resistant cancer cellsJudith Michels, Florine Obrist, Ilio Vitale, et al.
The EMBO Journal|June 8, 2018
Metabolic vulnerability of cisplatin-resistant cancersFlorine Obrist, Judith Michels, Sylvere Durand, et al.
Cell Cycle (Georgetown, Tex.)|February 23, 2013
Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancerJudith Michels, Ilio Vitale, Laura Senovilla, et al.
Bulletin Du Cancer|March 2, 2023
[Current post-surgical treatment strategies in first-line ovarian cancer]Kaïssa Ouali, Judith Michels, Felix Blanc-Durand, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2016
Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumoursMarco Gizzi, Lucie Oberic, Christophe Massard, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2017
Corrigendum to "Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours" [Eur J Cancer 69 (2016) 151-157]Marco Gizzi, Lucie Oberic, Christophe Massard, et al.
International Journal of Molecular Sciences|July 29, 2023
Combined Tumor-Based <i>BRCA1/2</i> and <i>TP53</i> Mutation Testing in Ovarian CancerEdith Borcoman, Elizabeth Santana Dos Santos, Catherine Genestie, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Cell Cycle (Georgetown, Tex.)|January 5, 2013
Vitamin B6 metabolism influences the intracellular accumulation of cisplatinLorenzo Galluzzi, Sabrina Marsili, Ilio Vitale, et al.
Bulletin Du Cancer|November 14, 2024
[Practical application of the 2023 FIGO classification for endometrial cancer]Solène Grosse, Catherine Genestie, Stéphanie Scherier, et al.
Plos One|June 6, 2012
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinomaOlivier Mir, Romain Coriat, Benoit Blanchet, et al.
Biochemical Pharmacology|August 10, 2014
MCL-1 dependency of cisplatin-resistant cancer cellsJudith Michels, Florine Obrist, Ilio Vitale, et al.
The EMBO Journal|June 8, 2018
Metabolic vulnerability of cisplatin-resistant cancersFlorine Obrist, Judith Michels, Sylvere Durand, et al.
Cell Cycle (Georgetown, Tex.)|February 23, 2013
Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancerJudith Michels, Ilio Vitale, Laura Senovilla, et al.
Bulletin Du Cancer|March 2, 2023
[Current post-surgical treatment strategies in first-line ovarian cancer]Kaïssa Ouali, Judith Michels, Felix Blanc-Durand, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2016
Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumoursMarco Gizzi, Lucie Oberic, Christophe Massard, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2017
Corrigendum to "Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours" [Eur J Cancer 69 (2016) 151-157]Marco Gizzi, Lucie Oberic, Christophe Massard, et al.
International Journal of Molecular Sciences|July 29, 2023
Combined Tumor-Based <i>BRCA1/2</i> and <i>TP53</i> Mutation Testing in Ovarian CancerEdith Borcoman, Elizabeth Santana Dos Santos, Catherine Genestie, et al.
Pageof 5